The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 13 2025
0mins
Source: Globenewswire
Conference Participation: The Oncology Institute, Inc. (TOI) will have CEO Dr. Daniel Virnich and CFO Rob Carter attending B. Riley’s 25th Annual Institutional Investor Conference on May 21, 2025, in Marina Del Rey, CA.
About The Oncology Institute: Founded in 2007, TOI is a leading value-based oncology group providing specialized cancer care to over 1.8 million patients through advanced services and a large team of clinicians across more than 70 locations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
